TI
MNTA

Turner Investments’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Turner Investments’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-61,750
Closed -$929K – 295
2016
Q4 		$929K Sell
61,750
-17,737
-22% -$234K 0.38% 100
2016
Q3 		$929K Sell
79,487
-114,527
-59% -$1.35M 0.31% 108
2016
Q2 		$2.1M Sell
194,014
-116,086
-37% -$1.2M 0.66% 53
2016
Q1 		$2.87M Buy
+310,100
New +$3.34M 0.78% 44

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Turner Investments's MNTA Position: Q1 2017 in Review

Turner Investments sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2017, closing a stake of 61,750 shares — an estimated $929K sold.

Turner Investments first reported a position in MNTA in Q1 2016 and held it in 4 quarters. The position peaked at $2.87M in Q1 2016. 162 funds tracked by Wall St. Rank hold MNTA as of Q1 2017.

  • Turner Investments reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Turner Investments sold 61,750 Momenta Pharmaceuticals, Inc. shares in Q1 2017, an estimated $929K.
  • Turner Investments first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2016 and held it in 4 quarters.
  • Turner Investments's Momenta Pharmaceuticals, Inc. position peaked at $2.87M in Q1 2016.
  • 162 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.